Journal of Peking University (Health Sciences) ›› 2022, Vol. 54 ›› Issue (2): 289-293. doi: 10.19723/j.issn.1671-167X.2022.02.015

Previous Articles     Next Articles

Effect of dexamethasone combined with oxybuprocaine hydrochloride gel on prevention of postoperative sore throat after nasal endoscopy

SHI Cheng-mei1,WANG Xue-dong1,LIU You-kun2,DENG Ying1,GUO Xiang-yang1,()   

  1. 1. Department of Anesthesiology, Peking University Third Hospital, Beijing 100191, China
    2. Department of Anesthesiology, Beijing Zhongguancun Hospital, Beijing 100080, China
  • Received:2020-03-09 Online:2022-04-18 Published:2022-04-13
  • Contact: Xiang-yang GUO E-mail:puthmzk@hsc.pku.edu.cn
  • Supported by:
    National Natural Science Foundation of China(81801070)

Abstract:

Objective: To explore the effectiveness and feasibility of dexamethasone combined with oxybuprocaine hydrochloride gel on the prevention of postoperative sore throat after nasal endoscopy. Methods: In the study, 60 patients with American Society of Anesthesiologist (ASA) physical statuses Ⅰ to Ⅱ, aged 18 to 72 years, scheduled for elective nasal endoscope surgery under general anesthesia requiring endotracheal intubation were randomly divided into dexamethasone combined with oxybuprocaine hydrochloride gel group (G group, n=30) and control group (C group, n=30). The patients in the G group received dexamethasone 0.1 mg/kg before induction and the oxybuprocaine gel was applied to the endotracheal catheter cuff and the front end within 15 cm. The patients in the C group received the same dose of saline and the saline was applied to the endotracheal catheter cuff and the front end within 15 cm. Then, all the patients in the two groups received the same induction and anesthesia maintainance. The operation time, anesthesia time, emergence time, extubation time and departure time were recorded. The intraoperative infusion volume, blood loss volume, propofol, remifentanil, rocuronium dosage were also recorded. The adverse reactions such as intraoperative hypotension, bradycardia and postoperative agitation were recorded. The postoperative sore throat score was recorded at the end of operation and 4 h, 8 h, 12 h, and 24 h after operation. Results: Compared with the C group, the emergence time [(8.4±3.9) min vs. (10.8±4.7) min], extubation time [(8.8±3.7) min vs. (11.9±4.8) min], and departure time [(20.0±5.3) min vs. (23.0±5.8) min] were significantly shorter, and the propofol dosage [(11.8±1.8) mg/kg vs. (15.9±4.6) mg/kg], remifentanil dosage [(10.9±4.7) μg/kg vs. (14.1±3.6) μg/kg] were significantly less in the G group, and there was no difference of rocuronium dosage in the two groups. Compared with the C group the incidence of intraoperative hypotension [10%(3/30) vs. 30%(9/30)], bradycardia [16.7%(5/30) vs. 20%(6/30)] and postoperative agitation [6.7%(2/30) vs. 23.3%(7/30)] were significantly lower in the C group. The postoperative sore throat score at the end of operation, 4 h, 8 h, 12 h and 24 h after operation in the G group were significantly lower than in the C group respectively [0 (0, 1) vs. 1 (1, 2), 0 (0, 0) vs. 1 (1, 2), 0 (0, 0) vs. 1 (1, 2), 0 (0, 0) vs. 1 (0.75, 1), 0 (0, 0) vs. 1 (0, 1)]. Conclusion: Dexamethasone combined with oxybuprocaine hydrochloride gel was effective and feasible on the prevention of postoperative sore throat after nasal endoscopy.

Key words: Dexamethasone, Oxybuprocaine hydrochloride gel, Postoperative sore throat, Nasal endoscopy

CLC Number: 

  • R765.9

Table 1

Demographic characteristics of the two groups"

Items Group G (n=30) Group C (n=30)
Gender, female/male 13/17 12/18
Age/years, x -±s 39.5±15.5 43.5±12.9
Height/cm, x -±s 168.6±7.2 166.1±5.7
Weight/kg, x -±s 68.4±14.1 66.5±10.7
Mallampati grade, M(P25, P75) 2 (1, 2.25) 2 (1, 2)

Table 2

Intraoperative conditions of the two groups ( x -±s)"

Items Group G (n=30) Group C (n=30)
Operating time/min 85.2±46.6 76.3±50.9
Transfusion volume/mL 800.0±249.1 786.7±315.9
Blood loss/mL 18.5±9.2 13.7±6.5

Table 3

Anesthesia conditions of the two groups ( x -±s)"

Items Group G
(n=30)
Group C
(n=30)
Anesthesia time/min 103.8±50.2 94.3±51.7
Emergence time/min 8.4±3.9* 10.8±4.7
Extubation time/min 8.8±3.7* 11.9±4.8
Departure time/min 20.0±5.3* 23.0±5.8
Propofol dosage/mg 805.8±259.1* 1 057.7±500.1
Remifentanil dosage/μg 748.3±340.3* 938.7±392.5
Muscular relaxant dosage/mg 48.3±4.6 49.5±12.6

Table 4

Complications of the two groups"

Items Group G (n=30) Group C (n=30)
Hypotension, n(%) 3 (10.0)* 9 (30.0)
Bradycardia, n(%) 5 (16.7)* 6 (20.0)
Postoperative agitation, n(%) 2 (6.7)* 7 (23.3)

Table 5

Postoperative sore throat score of the two groups"

Items Sore throat Group G
(n=30)
Group C
(n=30)
Sore throat score M(P25, P75) 95%CI
Group G (n=30) Group C (n=30) Median difference Low High
End of operation 0 21 6 0 (0, 1)* 1 (1, 2) 1 0.074 0.176
1 9 16
2 0 7
3 0 1
4 h after operation 0 25 6 0 (0, 0)* 1 (1, 2) 1 0.114 0.256
1 5 17
2 0 6
3 0 1
8 h after operation 0 27 7 0 (0, 0)* 1 (1, 2) 1 0.312 0.094
1 3 16
2 0 7
3 0 0
12 h after operation 0 27 8 0 (0, 0)* 1 (0.75, 1) 1 0.042 0.113
1 3 19
2 0 3
3 0 0
24 h after operation 0 27 13 0 (0, 0)* 1 (0, 1) 1 0.156 0.271
1 3 15
2 0 2
3 0 0
[1] 包丽, 曲鸣宇, 肖昭扬. 气管插管全麻术后咽喉部相关并发症的研究进展[J]. 临床麻醉学杂志, 2018, 34(5):501-504.
[2] Knoll H, Ziegeler S, Schreiber JU, et al. Airway injuries after one-lung ventilation: A comparison between double-lumen tube and endobronchial blocker: A randomized, prospective, controlled trial[J]. Anesthesiology, 2006, 105(3):471-477.
doi: 10.1097/00000542-200609000-00009
[3] Tanaka Y, Nakayama T, Nishimori M, et al. Lidocaine for preventing postoperative sore throat[J]. Cochrane Database Syst Rev, 2015(7): CD004081.
[4] Flexman AM, Duggan LV. Postoperative sore throat: Inevitable side effect or preventable nuisance[J]. Can J Anaesth, 2019, 66(9):1009-1013.
doi: 10.1007/s12630-019-01397-6 pmid: 31114939
[5] Jaensson M, Gupta A, Nilsson UG. Risk factors for development of postoperative sore throat and hoarseness after endotracheal intubation in women: A secondary analysis[J]. AANA J, 2012, 80(Suppl 4):S67-73.
[6] Narimani M, Seyed Mehdi SA, Gholami F, et al. The effect of betamethasone gel and lidocaine jelly applied over tracheal tube cuff on postoperative sore throat, cough, and hoarseness[J]. J Perianesth Nurs, 2016, 31(4):298-302.
doi: 10.1016/j.jopan.2015.08.012 pmid: 27444761
[7] Fayyaz A, Furqan A, Ammar A, et al. Comparing the effectiveness of betamethasone gel with lidocaine gel local application on endotracheal tube in preventing post-operative sore throat (POST)[J]. J Pak Med Assoc, 2017, 67(6):873-876.
pmid: 28585585
[8] Biro P, Seifert B, Pasch T. Complaints of sore throat after tracheal intubation: A prospective evaluation[J]. Eur J Anaesthesiol, 2005, 22(4):307-311.
doi: 10.1017/S0265021505000529
[9] Kuriyama A, Maeda H. Preoperative intravenous dexamethasone prevents tracheal intubation-related sore throat in adult surgical patients: A systematic review and meta-analysis[J]. Can J Anaesth, 2019, 66(5):562-575.
doi: 10.1007/s12630-018-01288-2 pmid: 30617677
[10] Zhao X, Cao X, Li Q. Dexamethasone for the prevention of postoperative sore throat: A systematic review and meta-analysis[J]. J Clin Anesth, 2015, 27(1):45-50.
doi: 10.1016/j.jclinane.2014.06.014
[11] Areeruk P, Ittichaikulthol W, Termpornlert S, et al. The effect of a single dose dexamethasone on postoperative pain in patients undergoing gynecological laparotomy surgery[J]. J Med Assoc Thai, 2016, 99(11):1239-1244.
[12] Park SY, Kim SH, Lee AR, et al. Prophylactic effect of dexamethasone in reducing postoperative sore throat[J]. Korean J Anesthesiol, 2010, 58(1):15-19.
doi: 10.4097/kjae.2010.58.1.15
[13] Bagchi D, Mandal MC, Das S, et al. Efficacy of intravenous dexamethasone to reduce incidence of postoperative sore throat: A prospective randomized controlled trial[J]. J Anaesthesiol Clin Pharmacol, 2012, 28(4):477-480.
doi: 10.4103/0970-9185.101920
[14] 郎宇, 王天龙, 张雁华, 张敏. 利多卡因凝胶作为喉罩润滑剂的临床观察[J]. 临床麻醉学杂志, 2010, 26(9):817-818.
[15] 焦亮, 刘瑞昌. 地佐辛和氟比洛芬酯用于颌面外科手术全身麻醉气管插管术后咽喉痛的比较[J]. 北京大学学报(医学版), 2014, 46(1):104-106.
[16] Hung CH, Liu KS, Shao DZ, et al. The systemic toxicity of equipotent proxymetacaine, oxybuprocaine, and bupivacaine during continuous intravenous infusion in rats[J]. Anesth Analg, 2010, 110(1):238-242.
doi: 10.1213/ANE.0b013e3181bf6acf
[17] Yu D, Chai W, Sun X, Yao L. Emergence agitation in adults: Risk factors in 2 000 patients[J]. Can J Anaesth. 2010, 57(9):843-848.
doi: 10.1007/s12630-010-9338-9
[18] 张国智, 王晓, 魏新川, 等. 恩纳乳膏气管导管表面涂布行气管粘膜表面麻醉的可行性[J]. 中华麻醉学杂志, 2003, 23(7):548-550.
[19] 刘晓荣, 詹大兴, 王成夭. 氢化泼尼松联合帕瑞昔布钠对双腔支气管插管术后咽喉痛的影响[J]. 临床麻醉学杂志, 2013, 29(8):746-748.
[20] 陈霞, 戚思华. 药物防治全身麻醉气管插管术后咽喉痛的研究进展[J]. 新医学, 2016, 47(4):218-221.
[21] 贾慧, 刘静, 李真, 等. 全身麻醉中两种插管方式对术后咽喉疼痛的影响[J]. 临床麻醉学杂志, 2014, 30(2):166-168.
[22] Chen KT, Tzeng JI, Lu CL, et al. Risk factors associated with postoperative sore throat after tracheal intubation: An evaluation in the postanesthetic recovery room[J]. Acta Anaesthesiol Taiwan, 2004, 42(1):3-8.
[23] Morris LG, Zoumalan RA, Roccaforte JD, et al. Monitoring tracheal tube cuff pressures in the intensive care unit: A comparison of digital palpation and manometry[J]. Ann Otol Rhinol Laryngol, 2007, 116(9):639-642.
doi: 10.1177/000348940711600902
[24] Chinachoti T, Pojai S, Sooksri N, et al. Risk factors of post-operative sore throat and hoarseness[J]. J Med Assoc Thai, 2017, 100(4):463-468.
pmid: 29911921
[1] WANG Li-xin , XU Xiao, NI Yao-feng, SUN Hai-tao, YU Ri-yue, WEI Shi-cheng. In vivo study of liposome-modified polyetheretherketone implant on bacteriostasis and osseointegration [J]. Journal of Peking University (Health Sciences), 2021, 53(4): 758-763.
[2] LI Zhi-Hong, LIU Dan, HE Zi-Jing, FAN Zhi-Yi. Influence of dexamethasone on the incidence of postoperative nausea and vomiting in breast cancer patients with neoadjuvant chemotherapy [J]. Journal of Peking University(Health Sciences), 2015, 47(4): 685-689.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 125 -128 .
[2] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 135 -140 .
[3] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 188 -191 .
[4] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 217 -220 .
[5] . [J]. Journal of Peking University(Health Sciences), 2009, 41(1): 52 -55 .
[6] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 310 -314 .
[7] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 333 -336 .
[8] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 225 -328 .
[9] . [J]. Journal of Peking University(Health Sciences), 2007, 39(4): 355 -360 .
[10] . [J]. Journal of Peking University(Health Sciences), 2007, 39(4): 365 -368 .